https://www.selleckchem.com/pr....oducts/nvp-bsk805.ht
Aripiprazole and olanzapine are atypical antipsychotics. Both drugs can induce metabolic changes; however, the metabolic side effects produced by aripiprazole are more benign. The aim of the study was to evaluate if aripiprazole and olanzapine alter prolactin levels, lipid and glucose metabolism and hepatic, haematological, thyroid and renal function. Twenty-four healthy volunteers received a daily oral dose of 10mg aripiprazole and 5mg olanzapine tablets for 5days in a crossover randomised clinical trial and were genotyped for 51 po
Like
Comment
Share
